Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-08-08

FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam from Mylan Pharmaceuticals Inc., indicating regulatory approval for a supplemental change to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)